We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Greiner Bio-One

Download Mobile App




Image: Bio-Rad launches serology assay for detection of coronavirus antibodies (Photo courtesy of Bio-Rad Laboratories, Inc.)

Bio-Rad Launches Serology Assay for Detection of Coronavirus Antibodies

Bio-Rad Laboratories, Inc. (Hercules, CA, USA) has launched a blood-based immunoassay kit to identify antibodies to the coronavirus SARS-CoV-2, the virus associated with COVID-19. More...
09 Apr 2020
Illustration

Canon Medical Developing Rapid Genetic Testing System for Novel Coronavirus

Canon Medical Systems Corporation (Ohtawara, Japan) has commenced the development of a rapid genetic testing system for the novel coronavirus (COVID-19). The project is part of a research program focusing on the development of diagnostic methods for COVID-19 led by the Japan Agency for Medical Research and Development (AMED). More...
08 Apr 2020
Image: The Cue Health Monitoring System (Photo courtesy of Cue Health Inc.)

Rapid, Portable, Point-of-Care COVID-19 Test Receives USD 13 Million Funding from BARDA

Cue Health Inc. (San Diego, CA, USA), a healthcare technology company, has been awarded a USD 13 million contract to accelerate the development, validation and FDA clearance of a portable, molecular diagnostic test capable of detecting SARS-CoV-2, the virus that causes COVID-19, in less than 25 minutes using a simple nasal swab. More...
07 Apr 2020
Image: The AcroMetrix Coronavirus 2019 (COVID-19) RNA Control (Photo courtesy of Thermo Fisher Scientific Inc.)

Thermo Fisher Launches New AcroMetrix Coronavirus 2019 (COVID-19) RNA Control

Thermo Fisher Scientific Inc. (Waltham, MA, USA) has launched the AcroMetrix Coronavirus 2019 (COVID-19) RNA Control, its latest quality control product to monitor and validate COVID-19 molecular diagnostic tests. More...
07 Apr 2020
Illustration

New Coronavirus (COVID-19) Antibody Test Can Help Determine Past COVID Infection

Eurofins Scientific’s (Luxembourg) US clinical diagnostics network is offering blood-based antibody testing for Coronavirus SARS-CoV-2 that can identify people who were exposed, may have developed some level of immunity to COVID-19 but potentially had mild to no symptoms. Eurofins' network will initially run nearly 5,000 tests per day, or 200 results every hour, helping first responders and healthcare providers. More...
07 Apr 2020
Image: The Fluxergy Analyzer (Photo courtesy of Fluxergy LLC)

Fluxergy Submits FDA EUA Request for One-Hour COVID-19 POC Test

Fluxergy LLC (Irvine, CA, USA), a research and medical diagnostic test company, has submitted an Emergency Use Authorization (EUA) request to the U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health, seeking an authorization that would permit medical professionals to begin using the company’s high-speed Research Use Only (RUO) test system as a COVID-19 diagnostic at the point-of-care (POC). More...
06 Apr 2020
Image: The NEXTGENPCR thermocycler (Photo courtesy of Molecular Biology Systems, B.V.)

NEXTGENPCR Endpoint Thermocycler Decreases PCR Amplification Time for SARS-CoV-2 to Eight Minutes

Molecular Biology Systems, B.V. (Goes, The Netherlands), a biotechnology company, has developed a method using its NEXTGENPCR endpoint thermocycler and consumables that decreases PCR amplification time for SARS-CoV-2 to eight minutes. More...
06 Apr 2020
Copyright © 2000-2020 Globetech Media. All rights reserved.